Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Maybe NEWS MARCH 1st.......SZLS
View:
Post by Oilersgoforcup on Feb 26, 2021 2:59pm

Maybe NEWS MARCH 1st.......SZLS

I am keeping my fingers crossed we get News March 1st.....already bet the FARM now i just have to wait to see if TRIPP Delivers....good luck to all !!
Comment by capebretongirl on Feb 26, 2021 3:08pm
What I don't get is that any fool would know that the day Aristotle is announced, that announcement alone will see a massive green day.  Investors should be flocking in as that date can come at any time.  How can there not be a more "sure thing" out there on that basis alone!!
Comment by cactuseskimo on Feb 26, 2021 3:13pm
This stock is actually holding fairly well to other speculative plays I have. Yeah, 1.25 sucks compared to a 1.60, but I was pretty excited to be in the 1.10 region just over 10 days ago. At any rate, I'm glad to be done with February trading, because MARCH IS THE MONTH!!! Well, unless Tripp royally screws things up and doesn't launch Aristotle on time and is late with the q4 report . . .  ...more  
Comment by Mermer2328 on Feb 26, 2021 7:48pm
with all due respect CBG, you and most of us here are well aware of the past and inaccurate guidance from Mr. Tripp. So to suggest it's a "sure thing" is a bit of a stretch, and that's why the SP is not moving like we want. I do agree when the huge NR comes, it will be historic for SZLS and its investors. Good Luck
Comment by capebretongirl on Feb 26, 2021 8:46pm
Mermer - what I was saying is that Aristotle is a sure bet as a winner when it comes out and it can come out any day.  I have expressed concern before that this could be delayed.
Comment by Mermer2328 on Feb 26, 2021 8:51pm
Fair enough. but it's still in the company's best interest to gain investor confidence again. That includes hitting self stated goals and timelines.. Were on the same page... I think Aristotle is better than sliced bread! Have a great weekend
Comment by Nailbiter1 on Feb 26, 2021 8:51pm
This post has been removed in accordance with Community Policy
Comment by MarketMoney on Feb 26, 2021 9:29pm
Nailbiter1 I will add Riggs as already a foot in NASDAQ as an insider. I'm guessing their plans to go NASDAQ is already figure out or in the making.
Comment by CageHill on Feb 26, 2021 10:35pm
How would that affect current shareholders on TSX if SZLS goes onto NASDAQ?
Comment by Nailbiter1 on Feb 26, 2021 10:41pm
This post has been removed in accordance with Community Policy
Comment by LionWhisperer on Feb 26, 2021 11:14pm
This post has been removed in accordance with Community Policy
Comment by MarketMoney on Feb 27, 2021 6:42am
Without any doubt I prefer dual listing with a stock that has low share float like SZLS. More means to trade a stock and easier to keep it liquid. That's what apealing right now is they only have less than 61 millions shares, for a bio company it's nice if they can keep it that way until they join NASDAQ. If they need to finance another PP, now with all the attention they got and with ...more  
Comment by RelevantStock on Feb 27, 2021 9:43am
Me too, however in the case of Stagezero there is certainly a good balance to achieve, and they've worked on that a little bit lately with the interviews, social media posts, etc. Frequent social media shouting companies indeed attract the wrong crowd, and they tend to have a very unhealthy amount of shorters and day traders sticked to them.  I am thinking of XSPA doing similar covid ...more  
Comment by MarketMoney on Feb 27, 2021 10:18am
  No worries for shorters, in a weekly stage 2, they are welcome :-) in a stage 3 and stage 4 there your worst enemy. As for daytrading, it's a momentum trade, no harms done in long run, they just follow the wave, they create volume like shorters create volume. As long you got the market on your side daytrading and shorting is noise when you look at the bigger picture (long term).  ...more  
Comment by capebretongirl on Feb 27, 2021 10:54am
There has been criticism about the lack of NRs promoting the introduction of Aristotle and I have certainly been in that camp as we discuss here what we think would be ideal for the company's marketing/commercialization efforts.   However, the reality is there is still time for Tripp to get at least one good NR out prior to Aristotle and do this right.  There are catalysts out ...more  
Comment by LithLover on Feb 27, 2021 11:13am
Cbg.  You've got mail  
Comment by CageHill on Feb 28, 2021 3:17am
Thanks Nails and Lion
Comment by InvrsContrarian on Feb 26, 2021 10:36pm
Funny thing is last year is my second go at playing the stocks and from my research at the beginning of the pandemic I had about 12 covid companies. Stagezero was labelled risky and at the bottom. Now to say I didn't have much money but I kept reading in my research that if you don't go for risky investments then your portfolio won't grow. So yea stagezero went to the top of the buy ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities